Adaptive Phase I & II Trials

Rapid approval, flexible conduct, adaptive protocols in a MHRA accredited facility.

View service

Phase III Clinical Studies

Fast and efficient patient recruitment for Phase III clinical trials.

View service

TQT Studies

Cardiac safety assessments are built into every clinical study.

View service

Bridging Studies

Fast track your global marketing authorisations with our ethnic bridging studies.

View service

Patient Recruitment

Fast and efficient in-house team, specialising in patient recruitment.

View service

Data Management

Flexible, efficient and tailored to our clients’ needs.

View service

Gene Editing & Gene Silencing

Richmond Pharmacology is at the forefront of gene editing.

View service

Regulatory Strategy Services

Strategic guidance for faster global regulatory approvals.

View service

Pharmacovigilance

Patient safety through expert adverse event monitoring

View service

Latest news

The Future of Cardiometabolic Research: Five Questions Shaping the Next Decade

October 22, 2026
Cardiometabolic research is continually evolving beyond explanations centred on single causes of disease.
Read more

Upcoming Event

AASLD

05 - 09 November 2026
Richmond Pharmacology is excited to join the AASLD Emerging Topic Conference: Unified Frontiers in Liver Disease in Denver, USA, on 05– 09 November 2026.
View event